Corporate actions
General
N V Chandrachoodamani

Corporate actions – do they tell you anything about a company’s future?

What’s a corporate action? They include bonuses, stock-splits and buy-backs and are some of the most welcomed corporate actions. Bonus shares are considered as a reward in the form of free shares. Stock splits are generally taken to be a measure to increase the liquidity in a stock. Buy-backs generally happen at a mature stage in the life-cycle of companies when they want to return excess cash. 

Read More
A lesser-known niche bio-tech player
Categories
N V Chandrachoodamani

Prime Stock Recommendation : A lesser-known niche bio-tech player

Specialty chemicals and API makers are the flavour of the season. Here is a lesser-known niche bio-tech player in the enzymes and probiotics space that is worth looking at. The world is becoming increasingly aware of the harmful effects of chemicals on health. Natural alternatives to boost the immune system are gaining traction…

Premium article available only to subscribers.

Read More
top-down and bottom-up
Categories
N V Chandrachoodamani

How to use top-down and bottom-up investing approaches to pick stocks

You would have heard fund managers talk about following a top-down and bottom-up approach. What are they? How do you use them to filter your stocks and when to use what? This article will try to touch upon some aspects of these approaches to investing, with screeners (from our own Stock Screener tool) that will illustrate and help you understand how to approach these strategies. 

Read More
Nifty Sectoral Indices
Categories
B Krishnakumar

Nifty Sectoral Indices: Outperformers & the promising ones

Even as the Sensex and the Nifty 50 scale new highs, how have the individual nifty sectoral indices performed? In this post, we’ll take a look at the sectoral indices in order to identify the outperforming and underperforming sectors. We shall also try to unearth the ones that are setting up well and could end up being the next outperforming sector. 

Premium article available only to subscribers.

Read More
InvIT option for income seekers
Categories
Aarati Krishnan

Prime Recommendation: A high-yielding InvIT option for income seekers

Indian investors looking for a high yielding InvIT option for income seekers with relative safety have very limited choices today. Infrastructure Investment Trusts or InvITs, which are a halfway house between stocks and bonds, offer such investors a shot at earning higher yields without high risk to their capital. 

Premium article available only to subscribers.

Read More
Banking and finance stocks, Understanding valuations of Banking & Finance Stocks
General
R Balakrishnan

Understanding valuations of banking and finance stocks

As an investor, your approach to analysing and choosing banking and finance stocks needs to be distinct too. In the first part of this article, I had dwelt on the CAMEL approach to deep-diving into a bank’s business.

Read More
Devyani International IPO, Devyani IPO, IPO, Devyani
Categories
Bhavana Acharya

IPO Review: Devyani International – Invest or Avoid?

On the heels of Zomato, Burger King, and Mrs Bectors comes the Devyani International IPO. This company runs the KFC and Pizza Hut chains across the country. It has other restaurant chains too, but the bulk of its revenues come from these two. Devyani International is aiming to raise approximately Rs 1,838 crore through its IPO.

Premium article available only to subscribers.

Read More
different commodity play
Categories
PrimeInvestor Research Team

Stock Recommendation: A different commodity play

Sugar stocks have been fired up lately on expectations that the industry is set to turn a corner. While the sector has seen many false dawns on reform hopes in the past, the changes we are seeing this time around could turn out to be the real deal.

Premium article available only to subscribers.

Read More
glenmark life sciences, glenmark life sciences ipo, IPO review
Categories
N V Chandrachoodamani

IPO Review: Glenmark Life Sciences – Should you invest?

Glenmark Life Sciences (GLS) is a generic API (Active Pharmaceutical Ingredients) manufacturer and a subsidiary of Glenmark Pharmaceuticals. The Glenmark Life Sciences IPO is worth Rs. 1,514 crore, comprising fresh issue of Rs.1,060 crore and an offer for sale worth Rs.454 crore by Glenmark Pharmaceuticals. Should you invest in the IPO of this high-value, non-commoditized API player?

Premium article available only to subscribers.

Read More
evaluate banking and finance stocks
Investment basics
R Balakrishnan

How to evaluate banking and finance stocks

There are certain characteristics which make evaluating banking and finance stocks different from others which produce goods and services. Money cannot be lent to someone unless there is an inflow by way of capital or debt. Since it is not practical to lend only from capital, borrowing (or leverage) is the sustaining food for this business. Naturally in using this leverage, there are good and bad apples.

Premium article available only to subscribers.

Read More
Login to your account
OR